News & Updates

Low-dose dasatinib seems to be safe and effective in intolerant patients with chronic phase (CP) chronic myelogenous leukaemia (CML), two case reports and review of the literature showed.

Using tranexamic acid (TXA) appears to lessen blood loss and the need for perioperative blood transfusion (PBT) without increasing the risk of venous thromboembolism (VTE) in patients with bladder cancer undergoing radical cystectomy, reports a study.

In patients with nonsmall cell lung cancer (NSCLC), plasma epidermal growth factor receptor (EGFR) mutation abundance shows a significant association with survival benefit, reveals a study.

Cetuximab therapy appears to induce skin complications in patients following central venous port placement, reports a study.

Enfortumab vedotin and pembrolizumab’s (EV+P) EV-302 trial results represent a major advancement in metastatic urothelial carcinoma (mUC), including in Asian patients, according to Professor Ravindran Kanesvaran of the National Cancer Centre in Singapore, who also discussed managing skin toxicity associated with this regimen and provided an overview of other agents for UC under investigation at Uro-Oncology Asia 2025.

A research team from the Faculty of Medicine, Chinese University of Hong Kong (CUHK) has identified molecular features in Epstein-Barr virus (EBV) DNA specifically associated with nasopharyngeal cancer (NPC) that differ significantly from the EBV DNA found in individuals with general EBV infections.

Microultrasonography-guided biopsy performs similarly as MRI/conventional ultrasonography fusion-guided biopsy in terms of detecting Gleason Grade Group 2 or higher prostate cancer in biopsy-naïve men, according to the results of the multicentre, international OPTIMUM study.